Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort

1. Puigvehí, M.
2. De Cuenca, B.
3. Viu, A.
4. Diago, M.
5. Turnes, J.
6. Gea, F.
7. Pascasio, J.M.
8. Lens, S.
9. Cabezas, J.
10. Badia, E.
11. Olveira, A.
12. Morillas, R.M.
13. Torras, X.
14. Montoliu, S.
15. Cordero, P.
16. Castro, J.L.
17. Salmerón, J.
18. Molina, E.
19. Sánchez-Ruano, J.J.
20. Moreno, J.
21. Antón, M.D.
22. Moreno, J.M.
23. De la Vega, J.
24. Calleja, J.L.
25. Carrión, J.A.